March 16, 2020: Cepheid wins $18 Million Sales Tax Exemption from CAEATFA for huge expansion in the Central Valley and SF Bay Area.

Contact: Sathish Kumar
Sr. Director, Consumables Operations
904 Caribbean Drive
Sunnyvale, CA 94089

Cepheid is a molecular diagnostics company that develops, manufactures and markets integrated testing systems for the clinical, and non-clinical, market.   Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 that received Emergency Use Authorization from the FDA in September 2020.

Because of the pandemic Cepheid has been thrust onto the global stage becoming part of the life science companies developing fast, reliable test of COVID-19.   A case was made that a large CAPEX investment in the San Joaquin Valley and SF Bay Area will help all California “Regions Rise Together” by growing biotech in a traditional agriculture-based economy (Lodi).   The CAEATFA award was unanimously approved and construction of a mega-factory in Lodi has begun.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply